Site-specific dephosphorylation of tau of apolipoprotein E-deficient and control mice by M1 muscarinic agonist treatment

Journal of Neurochemistry

Volumn 72, Issue 1, 1999, Pages 206-213

  Genis, I ^a   Fisher, A ^b   Michaelson, D M ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b ISRAEL INSTITUTE FOR BIOLOGICAL RESEARCH   (Israel)

Author keywords

1 Methylpiperidine 4 spiro (2' methylthiazoline); AF150(S); Apolipoprotein E; Dephosphorylation; M1 muscarinic agonist; Microtubule associated protein; Tau

Indexed keywords

1 METHYLPIPERIDINE 4 SPIRO (2' METHYLTHIAZOLINE); APOLIPOPROTEIN E; MUSCARINIC M1 RECEPTOR AGONIST; TAU PROTEIN; UNCLASSIFIED DRUG;

ACETYLCHOLINE BRAIN LEVEL; AMNESIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEPHOSPHORYLATION; MALE; MICROTUBULE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

ANIMALS; ANTIBODIES, MONOCLONAL; APOLIPOPROTEINS E; BLOTTING, WESTERN; BRAIN CHEMISTRY; EPITOPES; MALE; MICE; MICE, KNOCKOUT; MUSCARINIC AGONISTS; PHOSPHORYLATION; PIPERIDINES; RECEPTOR, MUSCARINIC M1; RECEPTORS, MUSCARINIC; TAU PROTEINS; THIAZOLES;

ANIMALIA;

EID: 0032935789     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1999.0720206.x     Document Type: Article

References (40)

1. Arendt T., Holzer M., Fruth R., Bruckner K., and Gartner U. (1995) Paired helical filament like phosphorylation of tau, deposition of β-A4-amyloid and memory impairment in rat reduced by chronic inhibition of phosphatase 1 and 2A. Neuroscience 69, 691-698.
2. 262 strongly reduces binding of tau to microtubules: distinction between PHF-like immunoreactivity and microtubule binding. Neuron 11, 153-163.
3. Billingsley M. L. and Kincaid R. L. (1997) Regulated phosphorylation and dephosphorylation of tau protein: effects on microtubule interaction, intracellular trafficking and neurodegeneration. Biochem. J. 323, 577-591.
4. 396 in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding. Neuron 10, 1089-1099.
5. Brandeis R., Sapir M., Hafif N., Abraham S., Oz N., Stein E., and Fisher A. (1995) AF150(S): a new functionally selective M1 agonist improved cognitive performance in rats. Pharmacol. Biochem. Behav. 51, 661-664.
6. Brion J.-P., Couck A.-M., Robertson J., Loviny T. L. F., and Anderton B. H. (1993) Neurofilament monoclonal antibodies RT97 and 8D8 recognize different modified epitopes in paired helical filament-τ in Alzheimer's disease. J. Neurochem. 60, 1372-1382.
7. Campbell T., Zemlan F. P., and Dean G. E. (1997) Detection of phosphorylated tau protein in cerebrospinal fluid of Alzheimer's patients. Soc. Neurosci. Abstr. 23, 1645.
8. Chapman S. and Michaelson D. M. (1998) Specific neurochemical derangements of brain projecting neurons in apolipoprotein E-deficient mice. J. Neurochem. 70, 708-714.
9. Drewes G., Lichtenberg-Kraag B., Doring F., Mandelkow E.-M., Biernat J., Goris J., Doree M., and Mandelkow E. (1992) Mitogen activated protein (MAP) kinase transforms tau protein into an Alzheimer-like state. EMBO J. 11, 2131-2138.
10. 1 muscarinic agonist treatment reverses cognitive and cholinergic impairments of apolipoprotein E-deficient mice. J. Neurochem. 70, 1991-1997.
11. Francis P. T., Gross A. J., and Bowen D. M. (1994) Neurotransmitters and neuropeptides in Alzheimer's disease (Terry R., Katzman R., and Bick K. L., eds), pp. 247-261. Raven Press, New York.
12. Friedhoff P. and Mandelkow E. (1998) Tau protein, in Guidebook to the Cytoskeletal and Motor Proteins (Kreis T. H. and Val R., eds), in press. Oxford University Press, New York.
13. Genis I., Gordon I., Sehayek E., and Michaelson D. M. (1995) Phosphorylation of tau in apolipoprotein E-deficient mice. Neurosci. Lett. 199, 5-8.
14. Goedert M. (1993) Tau protein and the neurofibrillary pathology of Alzheimer's disease. Trends Neurosci. 16, 460-465.
15. Goedert M., Spillantini M. G., Jakes R., Rutherford D., and Crowther R. A. (1989) Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease. Neuron 3, 519-526.
16. Goedert M., Jakes R., Crowther R. A., Cohen P., Vanmechelen E., Vandermeeren M., and Cras P. (1994) Epitope mapping of monoclonal antibodies to the paired helical filaments of Alzheimer's disease: identification of phosphorylation sites in tau. Biochem. J. 301, 871-877.
17. Gordon I., Grauer E., Genis I., Sehayek E., and Michaelson D. M. (1995) Memory deficits and cholinergic impairment in apolipoprotein E-deficient mice. Neurosci. Lett. 199, 1-4.
18. Grundke-Iqbal I., Iqbal K., Tung Y.-C., Quinlan M., Wisniewski H. M., and Binder L. I. (1986) Abnormal phosphorylations of the microtubule-associated protein tau in Alzheimer cytoskeletal pathology. Proc. Natl. Acad. Sci. USA 83, 4913-4917.
19. Gustke N., Steiner B., Mandelkow E. M., Biernat J., Meyer H. E., Goedert M., and Mandelkow E. (1992) The Alzheimer-like phosphorylation of tau protein reduces microtubule binding and involves Ser-Pro and Thr-Pro motifs. FEBS Lett. 307, 199-205.
20. Ishiguro K., Omori A., Soto K., Tomizawa K., Imahori K., and Uchida T. (1991) A serine/threonine proline kinase in the tau protein kinase fraction forming a paired filament epitope. Neurosci. Lett. 128, 195-198.
21. Kosik K. S. and Greenberg S. M. (1994) Tau protein and Alzheimer's disease, in Alzheimer's Disease (Terry R. D., Katzmann P., and Bick K. L., eds), pp. 335-344. Raven Press. New York.
22. Kosik K. S., Orecchio L. D., Binder L. I., Trojanowski J. Q., Lee V. M.-Y., and Lee G. (1988) Epitopes that span the tau molecule are shared with paired helical filaments. Neuron 1, 817-825.
23. Krugers H. J., Mulder M., Korf J., Havekes L., deKloot E. R., and Joils M. (1997) Altered synaptic plasticity in hippocampal CA1 area of apolipoprotein E deficient mice. Neuroreport 8, 2505-2510.
24. Krzywkowski P., Gagere J., Chabot C., Momoli F., Rochford J., Massicotte G., and Poirier J. (1997) Pharmacology of the cholinergic and glutaminergic systems in behaviorally impaired apoE knockout mice. Soc. Neurosci. Abstr. 23, 1895.
25. Lichtenberg-Kraag B., Mandelkow E.-M., Biernat J., Steiner B., Schröter C., Gustke N., Meyer H. E., and Mandelkow E. (1992) Phosphorylation-dependent epitopes of neurofilament antibodies on tau protein and relationship with Alzheimer tau. Proc. Natl. Acad. Sci. USA 89, 5384-5388.
26. Mandelkow E.-M. and Mandelkow E. (1993) Tau as a marker for Alzheimer's disease. Trends Biochem. Sci. 18, 480-483.
27. Mawal-Dewan M., Henley J., Van de Voorde A., Trojanowski J. A., and Lee V. M.-Y. (1994) The phosphorylation state of tau in the developing rat brain is regulated by phosphoprotein phosphatase. J. Biol. Chem. 269, 30981-30987.
28. Masliah E., Mallory G. N., Alford M., Veinberg I., and Roses A. D. (1995) Neurodegeneration in the central nervous system of apoE-deficient mice. Exp. Neurol. 136, 107-122.
29. Mercken L. and Brion J.-P. (1995) Phosphorylation of tau protein is not affected in mice lacking apolipoprotein E. Neuroreport 6, 2381-2384.
30. Mercken M., Vandermeeren M., Lubke U., Six J., Bioos J., Van de Voorda A., Martin J., and Gheuen J. (1992) Monoclonal antibodies with selective specificity for Alzheimer tau are directed against phosphatase-sensitive epitopes. Acta Neuropathol. (Berl.) 84, 265-272.
31. Morishima-Kawashima M., Hasegawa M., Takio K., Suzuki M., Yoshida H., Titani K., and Ihara Y. (1995) Proline-directed and nonproline-directed phosphorylation of PHF-tau. J. Biol. Chem. 270, 823-829.
32. Munoz-Montano J. R., Moreno F. J., Avila J., and Dias Nido J. (1997) Lithium inhibits Alzheimer's disease-like protein phosphorylation in neurons. FEBS Lett. 411, 183-188.
33. Oitzl M. S., Mudler M., Lucassen P. J., Havekes L. M., Grootendorst J., and de Kloet E. R. (1997) Severe learning deficits in apolipoprotein E-knockout mice in a water maze task. Brain Res. 752, 189-196.
34. Plump A. S., Smith J. D., Hayek T., Aalto-Setala K., Walsh A., Verstuyft J. G., Rubin E. M., and Breslow J. L. (1992) Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell 71, 343-353.
35. Roses A. D. (1994) Apolipoprotein E is a genetic locus that affects the role of Alzheimer's disease expression: β-amyloid burden is a secondary consequence dependent on apoE genotype and duration of disease. J. NeuropathoL Exp. Neurol. 53, 429-437.
36. Roses A. D. (1997) A model for susceptibility polymorphisms for complex diseases: apolipoprotein E and Alzheimer's disease. Neurogenetics 1, 3-11.
37. 1 muscarinic acetylcholine receptor regulates T phosphorylation in transfected PC12 cells. J. Neurochem. 66, 877-880.
38. Strittmatter W. J., Weisgraber K. H., Huang D. Y., Li-Ming D., Salversen G. J., Pericak-Vance M., Schmechel D., Saunders A. M., Goldgauer D., and Roses A. D. (1993) Binding of human apoliprotein E to synthetic amyloid beta peptide: isoform specific effects and implications for late onset Alzheimer's disease. Proc. Natl. Acad. Sci. USA 90, 8098-8102.
39. Vulliet R., Halloran S. M., Braun R. K., Smith A. J., and Lee G. (1992) Proline directed phosphorylation of human tau protein. J. Biol. Chem. 267, 22570-22574.
40. Zemlan F. P. and Dean G. E. (1996) Monoclonal antibody PHF1 recognizes phosphorylated serine 404 of tau protein and labels paired helical filaments. J. Neurosci. Res. 46, 90-97.